Cargando…

Overexpression of p53R2 is associated with poor prognosis in lung sarcomatoid carcinoma

BACKGROUND: This study aimmed to evaluate the expression of p53-inducible RR small subunit 2 homologue (p53R2) in Lung sarcomatoid carcinoma (LSC) and its association with clinicopathological parameters and prognosis. METHODS: In this study, clinicopathological factors and prognostic significance of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Jiewei, Xiao, Yongbo, Cai, Xiaoyan, Liu, Jun, Chen, Keming, Zhang, Xinke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731091/ https://www.ncbi.nlm.nih.gov/pubmed/29246119 http://dx.doi.org/10.1186/s12885-017-3811-6

Ejemplares similares

Overexpression of LBH is associated with poor prognosis in human hepatocellular carcinoma
por: Chen, Jiewei, et al.
Publicado: (2018)

Prognostic significance of preoperative peripheral blood neutrophil to lymphocyte ratio (NLR) in lung sarcomatoid carcinoma
por: Liu, Jun, et al.
Publicado: (2019)

CD8+ tumor-infiltrating lymphocytes as a novel prognostic biomarker in lung sarcomatoid carcinoma, a rare subtype of lung cancer
por: Chen, Jiewei, et al.
Publicado: (2018)

Overexpression of α-sma-positive fibroblasts (CAFs) in Nasopharyngeal Carcinoma Predicts Poor Prognosis
por: Chen, Jiewei, et al.
Publicado: (2017)

The Prognostic Significance Of JMJD3 In Primary Sarcomatoid Carcinoma Of The Lung, A Rare Subtype Of Lung Cancer
por: Li, Shuman, et al.
Publicado: (2019)

p53R2 as a novel prognostic biomarker in nasopharyngeal carcinoma
por: Chen, Jiewei, et al.
Publicado: (2017)

Low expression of ZMYND8 correlates with aggressive features and poor prognosis in nasopharyngeal carcinoma
por: Chen, Jiewei, et al.
Publicado: (2019)

Sarcomatoid carcinoma of colon: extremely poor prognosis
por: Choi, Yoon Young, et al.
Publicado: (2011)

Poor prognosis of pulmonary sarcomatoid carcinoma with KRAS mutation and ALK fusion
por: Chen, Fangmin, et al.
Publicado: (2019)

Pten and p53 Loss in the Mouse Lung Causes Adenocarcinoma and Sarcomatoid Carcinoma
por: Lázaro, Sara, et al.
Publicado: (2022)

Sarcomatoid carcinoma of the lung
por: Karmakar, Saurabh, et al.
Publicado: (2021)

Sarcomatoid carcinoma of the lung with brain metastases
por: de Oliveira, Matheus Fernandes, et al.
Publicado: (2013)

Overexpression of EFEMP1 Correlates with Tumor Progression and Poor Prognosis in Human Ovarian Carcinoma
por: Chen, Jie, et al.
Publicado: (2013)

Long-term outcomes and prognosis for patients with sarcomatoid hepatocellular carcinoma
por: Zhou, Cheng, et al.
Publicado: (2022)

Genetic testing and prognosis of sarcomatoid hepatocellular carcinoma patients
por: Jia, Bin, et al.
Publicado: (2023)

Immunohistochemical evaluation of mismatch repair proteins and p53 expression in extrauterine carcinosarcoma/sarcomatoid carcinoma
por: Kunc, Michał, et al.
Publicado: (2020)

p53 protein overexpression identifies a group of central primitive neuroectodermal tumours with poor prognosis.
por: Jaros, E., et al.
Publicado: (1993)

Downregulation of miR203 induces overexpression of PIK3CA and predicts poor prognosis of gastric cancer patients
por: Liang, Min, et al.
Publicado: (2015)

Comprehensive treatment for ROS1 ‐overexpressed pulmonary sarcomatoid carcinoma: A case report
por: Sun, Wei, et al.
Publicado: (2023)

DDIT4 overexpression associates with poor prognosis in lung adenocarcinoma
por: Song, Li, et al.
Publicado: (2021)

Sarcomatoid lung carcinomas: a case series
por: Hountis, Panagiotis, et al.
Publicado: (2009)

SKA1 overexpression is associated with poor prognosis in hepatocellular carcinoma
por: Chen, Yibing, et al.
Publicado: (2018)

Overexpressed RING Finger 44 Correlates with Poor Prognosis in Hepatocellular Carcinoma
por: Liu, Yue, et al.
Publicado: (2022)

Metabolic Pathways Enhancement Confers Poor Prognosis in p53 Exon Mutant Hepatocellular Carcinoma
por: Chen, Po-Ming, et al.
Publicado: (2020)

Immunophenotyping of pulmonary sarcomatoid carcinoma
por: Ma, Yu, et al.
Publicado: (2022)

miR-20b overexpression is predictive of poor prognosis in gastric cancer
por: Xue, Tong-min, et al.
Publicado: (2015)

Overexpression of RACK1 Predicts Poor Prognosis in Melanoma
por: Shen, Congcong, et al.
Publicado: (2020)

p53 overexpression is a prognosticator of poor outcome in esophageal cancer
por: Melling, Nathaniel, et al.
Publicado: (2019)

Sarcomatoid Carcinoma of the Prostate
por: Açıkgöz, Onur, et al.
Publicado: (2013)

Sarcomatoid carcinoma of the cervix
por: Nageeti, Tahani H., et al.
Publicado: (2012)

Serpin peptidase inhibitor, clade A member 3 (SERPINA3), is overexpressed in glioma and associated with poor prognosis in glioma patients
por: Luo, Dingyuan, et al.
Publicado: (2017)

Overexpression of epithelial cell transforming 2 protein in colorectal carcinoma predicts a poor prognosis
por: Li, Yiming, et al.
Publicado: (2017)

Sarcomatoid intrahepatic cholangiocarcinoma in a patient with poor prognosis: a case report and literature review
por: Li, Xu, et al.
Publicado: (2020)

Overexpression of miR-210 is Associated with Poor Prognosis of Acute Myeloid Leukemia
por: Tang, Xiaoqiong, et al.
Publicado: (2015)

Overexpression of RBBP6, Alone or Combined with Mutant TP53, Is Predictive of Poor Prognosis in Colon Cancer
por: Chen, Jian, et al.
Publicado: (2013)

Sarcomatoid Carcinoma of the Lung: A Model of Resistance of Chemotherapy
por: Ouziane, Imane, et al.
Publicado: (2014)

Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma
por: Li, Mei-Xiang, et al.
Publicado: (2021)

The poor prognosis of sarcomatoid carcinoma arising from low grade serous ovarian cancer: A case report and review of the literature
por: Haight, Paulina, et al.
Publicado: (2021)

miRNAs-mediated overexpression of Periostin is correlated with poor prognosis and immune infiltration in lung squamous cell carcinoma
por: Bai, Xu, et al.
Publicado: (2022)

Increased Expression of SETD7 Promotes Cell Proliferation by Regulating Cell Cycle and Indicates Poor Prognosis in Hepatocellular Carcinoma
por: Chen, Yuanyuan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_p6mvvj6klgb9lkugnp8mksiv0e